- Summits
- Sponsorship
- Get Tickets
- Retreats
- Media Opportunities
- News
- About
Convention and Exhibition Centre (HKCEC), Hong Kong
2027
10:00 – 15:00
Your journey begins with a hotel pick-up by private coach, accompanied by an English-speaking guide, before transferring to Tung Chung to board the Ngong Ping 360 cable car. Enjoy a scenic 25-minute cable car ride to Ngong Ping Village, followed by a guided walking tour of Po Lin Monastery and the iconic Big Buddha, including the climb of its 268 steps. After the tour, you will have free time to explore Ngong Ping Village. In the afternoon, return to Tung Chung via the Ngong Ping 360 cable car before boarding your private coach for the transfer back to your hotel.
Only for Platinum Ticket Holders. Prior RSVP Required.
19:30 – 20:30
Awards Reception sponsored by CS Lifesciences brings together the people behind some of the most exciting developments in healthcare and medical technology. Celebrate achievements, reconnect with colleagues, and enjoy an evening of meaningful conversations with members of the global MedTech community.
Only for Platinum Ticket Holders.
20:30 – 22:30
The MedTech World Awards Asia, sponsored by Blue Goat Cyber, will mark our first-ever awards ceremony in Asia, taking place at the Grand Ballroom, Grand Hyatt Hong Kong. The event will celebrate excellence and innovation across the MedTech and HealthTech landscape, honoring startups, investors, clinicians, and ecosystem builders who are driving healthcare forward. This milestone ceremony will set the tone for recognizing MedTech leadership on a truly global stage.
Access is strictly limited to Platinum ticket holders, and prior RSVP is required.
09:00 – 18:00
Hong Kong Convention and Exhibition Centre
It’s all set this morning as MedTech World Asia officially gets underway. Plan your day by exploring the event floor, discovering our exhibitors and sponsors, and connecting with innovators from across the global MedTech ecosystem.
Find your way around with the event floor plan and browse the official Event Guide to learn more about our exhibitors, speakers, and sessions.
What to expect:
09:00 – 18:00
The agenda is designed for action in 2026, covering how to win in enterprise health systems, navigate market access and regulatory readiness, raise capital and plan for outcomes, partner with strategics and health systems, and spot the next wave of breakout innovation across robotics, women’s health, and emerging device categories. The conference will conclude with a live startup pitch competition, featuring a hand selected cohort presenting on stage in front of an investor judging panel.
Dr. Dylan Attard
CEO, Founder
MedTech World
MS Ming Cai
Secretary-General and General Manager
SCSS Smart Healthcare & Big Health Professional Committee and Shenzhen Innovation Bay Research Institute
Luo Jian (Robin)
Co- Founder
Wenfair International Network Technology Co., Ltd.
Xuefei Zhang
General Manager
Beijing Zhongchuang Hongjian Medical Technology Co., Ltd.
Positioning HK as a launchpad into Mainland China, Southeast Asia, and beyond. Leaders explore why HK’s regulatory environment, capital markets, and GBA proximity make it uniquely suited for MedTech companies seeking regional scale.
Adrian Lam
President & CEO
CorVista Health
Vicky Tse
Head of Life and Health Technology
Hong Kong Science and Technology Parks Corporation
Zoe Zhu
Director
EQT Group
Ken Wong
Executive Director
Hong Kong Life Sciences Society
Genesis Lai
Principal Manager (Life and Health Technology)
Office for Attracting Strategic Enterprises (OASES)
HUNG See Long Aaron
Senior Medical & Health Officer (Medical Device)
Medical Device Division, Department of Health, HKSAR
Dr Renzo De Gabriele
Permanent Secretary, Office of the Deputy Prime Minister and Ministry for Health
Office of the Deputy Prime Minister and Ministry for Health – Government of Malta
Expanding into Europe and the USA involves more than securing regulatory clearance. This panel will examine the evidence, reimbursement, pricing, adoption, and commercial strategies needed for successful market entry. Experts will also discuss regulatory expectations, quality systems, documentation requirements, and why cybersecurity should be embedded early in the expansion journey.
Assaf Barnea
Founder & Managing Partner
Sanara Capital
Christian Espinosa
CEO
Blue Goat Cyber
Merce Guerra
Associate Director, Regulatory Affairs Medtech
Alira Health
Edwin Lindsay
Principal Consultant / Managing Director
CS Lifesciences
Harry Blumsack
CEO
Infera
How Southeast Asian MedTech funding trends diverge from US and European markets. This panel examines investor risk appetite, deal structures, due diligence expectations, and the cultural nuances that shape how capital flows to innovation in Asia.
Ivanny Franklin
Managing Partner
MedSight Capital
Anand Govindaluri
Group CEO
Govin Capital
Vijay Karwal
Managing Director
CBC Group
Chris Japp
Partner
Tramway Ventures
Vinern Leow
Vice President
Ascend Capital Partners
Presenting Slot
Nadia Ivanova
Co-Founder & Chief Product Officer
Sparrow BioAcoustics
Dr. Rafael Veraza
CEO & President
Vascular Perfusion Solutions, Inc. (VPS)
Wengang Liu
CEO
Cimple Biotechnology Limited
Dr. Lydia Leung
CEO & Co-founder
Belun Technology
This panel explores how AI is transforming complex health data—such as genomics, imaging, and real-world evidence—into actionable insights for more personalized care. Experts will discuss real-world applications, challenges, and how we can accelerate the shift toward delivering the right treatment to the right patient at the right time.
Hawkins C. Gay, MD, MPH, MSAI
Cardiac Electrophysiologist
Northwestern Medicine, Bluhm Cardiovascular Institute
Dr. Alireza Daneshvar
Founder and CEO
Pioneera Biosciences
Dr. Kawther Al Belushi
Project Manager for the Development of the National Strategy of Oman and Research and Innovation Programs Expert
Oman Research and Innovation Authority
Jorgen Souness
CEO
St. Vincent De Paul
Dr. Alex Aliper
Co-Founder and President
Insilico Medicine
Wang Dongsheng
Chairman / Chief Scientist
Shenzhen XinnuoBei Biopharmaceutical Co., Ltd.
Hosted in Chancellor I & II, take this opportunity to enjoy lunch while connecting with healthcare leaders, innovators, investors, and fellow attendees. Exchange ideas, spark new collaborations, and build meaningful relationships in a relaxed networking environment.
Leading APAC VCs and family offices discuss investment priorities, what’s attracting capital across the region, and what founders misunderstand about raising from Asian investors. A candid look at which sectors and geographies are generating the strongest interest.
Alberto Chan
Co-Founder
RaiseHealth.co
Sunil Thakur
Partner and Head of South Asia
Quadria Capital
Scarlett Chen
Managing Partner
Verge HealthTech Fund
Fred Li
Managing Director and Head of University Ventures
Gobi Partners
Irene Hong
Founding Partner
CEC Capital Group
Everyone talks about Hong Kong’s health innovation ecosystem from the policy and GBA angle. This panel asks the people actually building it: the investors funding it, the infrastructure and cloud players enabling it, and the clinicians translating it into care. What does it really take to move an idea from lab to patient here, and who’s carrying that weight?
Angel Lam
Startup Territory Lead, Google Cloud Hong Kong
Google Hong Kong
Lincoln Heng
Investor
Verge HealthTech Fund
Dr. Charles Hu
Founder & CEO
Ryoden Medical Holdings Ltd
Anne Ma
Team Lead, Venture Fund
HKSTP (Hong Kong Science & Technology Parks Corporation)
Yiming Liu
Partner in Charge, Shanghai
Cooley
Presenting Slot
Xuan Luo
Associate Research Scientist & CEO
Hong Kong Center for Cerebro-cardiovascular Health Engineering (COCHE) & ANRim Biotech (HK) Limited
Dr. Junda Shen
Co-founder and CEO, Associate Research Scientist
LUMAT-SERS Limited, COCHE
Meaghan Kiely
Founder
NASELLA
Nir Israeli
CEO
EyeMed Technologies Ltd.
Bringing a medical technology to patients requires more than a great product. Success depends on generating the right clinical evidence, building trusted partnerships with healthcare systems, and designing studies that satisfy clinicians, regulators, investors, and future customers. The conversation would explore how founders can avoid common pitfalls, accelerate clinical validation, and build a commercialization strategy that starts with patients and ends with adoption.
Ken Nelson
Investor & Board Member
Nelson Jennings Ventures
Jules Bligh
Operations Director
Ascend CRO
Dr. Kenneth Tsang
Regional Chief Executive Officer
IHH Healthcare North Asia
Expanding across Asia is not a one-size-fits-all playbook. This session dives into the practical realities of entering and scaling across multiple APAC markets, covering regulatory sequencing, localization, partnerships, and go-to-market strategies needed to succeed in diverse healthcare systems.
Von Leong
Co Founder
Purpose Venture Capital and Philanthropy
William Hsu
Principal
William Hsu Consulting Inc
Gwendolin Mah
Head of International Programmes
MedTech Actuator
Dr. Xiao Qian
Partner & Director of Marketing
Ciphergene
Kevin Koh
Founder & CEO
Vivo Surgical
Designing products for markets with varying connectivity, data regulation, and digital literacy. This panel explores how to build digital health solutions that work across Asia’s diverse infrastructure conditions, from tier-1 cities to rural populations.
Joalin Lim
Founder & Group CEO
Agape-Life Medtech & Healthcare Group
Alok Mishra
CEO
Value Addition
Dr. Bernard Ng Kee Huat
Director Innovation, Enterprise & Commercialisation Office
Singapore General Hospital
Dr. Shravan Verma
Co-founder & Chief Executive Officer
Speedoc
Ronald Lo
General Manager
Roche Diagnostics, Hong Kong
Yulia Yurevich
Head of Client Relations & Partnerships
MedTech World
13:10 – 14:10
Connect with a select group of healthcare leaders, innovators, and industry experts at our exclusive invite-only luncheon, proudly sponsored by Blue Goat Cyber and CS LifeScience.
What separates a promising MedTech company from one that is genuinely ready for investment, international expansion, and acquisition? This fireside conversation brings together an investor and experts in regulatory strategy, quality, and cybersecurity to examine the risks that often emerge after initial interest but before a deal is completed. The discussion will explore what investors look for beyond the pitch deck, which gaps can delay or undermine a transaction
Joseph Ho
Director of Programs
University of Hong Kong
Christian Espinosa
Founder and CEO
Blue Goat Cyber
Edwin Lindsay
Principal Consultant & Managing Director
CS Life Sciences
Chris Japp
Partner
Tramway Ventures
19:00 – 21:30
The reception at Grill Bar, Grand Hyatt Hong Kong will offer an intimate setting for high-level networking among investors, CEOs, and industry leaders. Set against Hong Kong’s vibrant backdrop, the evening will combine fine hospitality with strategic introductions, fostering meaningful relationships that drive future collaborations. It’s where the conversations that shape MedTech’s next chapter will truly begin.
09:00 – 17:00
Hong Kong Convention and Exhibition Centre
It’s day two, and the momentum continues to build. Build on yesterday’s conversations, reconnect with new and familiar faces, discover exhibitors and innovations you may have missed, and make the most of the Media Lounge and dedicated meeting rooms to turn introductions into lasting partnerships. With the exhibition open until 18:00, there’s plenty of time to explore the floor, attend sessions, and schedule those final meetings.
What to expect:
09:00 – 18:00
The agenda is designed for action in 2026, covering how to win in enterprise health systems, navigate market access and regulatory readiness, raise capital and plan for outcomes, partner with strategics and health systems, and spot the next wave of breakout innovation across robotics, women’s health, and emerging device categories. The conference will conclude with a live startup pitch competition, featuring a hand selected cohort presenting on stage in front of an investor judging panel.
How the GBA policy framework, Shenzhen’s manufacturing base, and HK’s regulatory gateway create a unique launchpad for global MedTech companies. Panelists discuss practical strategies for navigating cross-border operations within the GBA.
Patrick Nowlin
CEO
Attuned HealthTech
Landon Lack
Founder & CEO
China MedConnect
Dr. Justin Cheng
CEO & Co-Founder
SmartCare Technology Co. Ltd.
Meng(Evan) YAN
Deputy General Manager
Hunan Xiangya Pharmaceutical Co., Ltd.
Wing Chu
Deputy Director of Research
HKTDC
Obesity can no longer be addressed through medication alone. The future will depend on the convergence of GLP-1 therapies, wearables, continuous health monitoring, AI-driven support, personalized prevention, stronger patient agency, and coordinated public policy. The keynote would also explore how China is increasingly treating obesity as a national priority, with government leadership and ecosystem-wide action, similar to the way major challenges such as sustainability and climate change are approached. The central message is simple: sustainable obesity management will require more than one drug or one device. It will require an integrated ecosystem combining medicine, technology, behaviour, and policy.
Philippe Gerwill
Founder and Managing Director
PGEA Limited
What regional and international investors want to see before writing the cheque. Panelists walk through the milestones, metrics, and narratives that move a MedTech company from early-stage funding to a credible path toward public markets in Asia.
Anastasia Miros
Partner
CFGI
Andrew Ng
Partner, Head of Healthcare
VMS Group
Kenneth Sun
Senior Vice President & Head of Asia
Royalty Pharma
Paul Li
Venture Partner
Aulis Capital
Jean Baptiste Roy
Partner
Seveno Capital
Robert Gangi
CEO/Founder
Lindo Technology Group
Stefano Pasquino
CEO
Tresquare Technologies
Peter Fedichev
Co-Founder and Chief Executive Officer
Gero
Zhen Yuan
Sr. Director, Digital Product Business
Intuitive Fosun
From diagnostics to therapeutics, what regional health systems are prioritising in women’s health. This panel examines the commercial opportunity, clinical evidence requirements, and cultural factors shaping FemTech adoption across Asian markets.
Lindsay Davis
Founder
FemTech Association Asia
Maxine Lam
Senior Scientist/ Scientific Founder
Agency for Science, Technology and Research (Singapore)
Dr. Clement Chia Luck Khng
Breast Surgeon & Clinician Innovator
Khoo Teck Puat Hospital
Dabriel Choi
Founder & CEO
EveryBaby Limited
Alyssa Than
Associate Director, Wellbeing Solutions – APAC
Aon
Presenting Slot
Scarlett Chen
Managing Partner
Verge HealthTech Fund
Dr. Joseph Mocanu
Partner
Verge HealthTech Fund
What separates funded startups from those that truly scale? Investors, founders, and accelerators share practical insights on validation, regulation, market entry, and execution across Asia.
Ajeesh Ashraf
Managing Partner
Blue Box Advancements
Lisa Cai
Portfolio Manager / Director
Pivotal Life Sciences / CEO's Office, Nan Fung Group
Jo Choi
Founder and Distributor
Honour Medical and RNAscence Biotechnology
Rajat Nag
Founder & CEO
VectorA GTM Pte Ltd
Dr. Christian Wende, LL.M.
Partner
K&L Gates
Join us in Chancellor I & II to enjoy a curated lunch while immersing yourself in one of the event’s most valuable networking opportunities. Connect with key stakeholders from across the MedTech value chain, exchange insights, and foster relationships that extend beyond the conference.
When corporate investment makes more sense than VC for MedTech scale-up. This panel explores CVC relationships, strategic partnership structures, and non-dilutive funding options that let companies accelerate growth without sacrificing control.
Mandy Wong
Managing Director
MergersCorp M&A International
Gavin Leonard
CEO
MedTech Syndicates
Wei Shen
Head of Principal Investment
Junson Capital
Martin Omid Akhavan
Managing Director
Anthro Ventures
From surgical platforms and robotic bronchoscopy to next-generation minimally invasive and remotely operated systems, medical robotics is expanding far beyond the traditional operating room. Which Asian markets are leading adoption, how are companies financing and scaling their expansion, and what does it take to build technologies that hospitals and clinicians will actually use? This panel will examine regulation, hospital adoption, clinical workflows, affordability, physician usability, and the competitive landscape across Chinese Mainland, Hong Kong, Singapore, and the wider Asia-Pacific region.
Nicholas Drysdale
Chief Financial Officer
XCath Robotics and EndoQuest Robotics
Jian Zhang
CEO
Noah Medical
Joey Liu
Global Marketing Director
Shanghai MicroPort MedBot (Group) Co.,Ltd
Arman Nadershahi
CEO
Endiatx
Chun Shi
Senior Director, Robotics and Digital, Surgery
Johnson & Johnson MedTech, China
Presenting Slot
Michael Tam
Chief Brand Officer
UBTECH Robotics Corp
India is rapidly emerging as a serious MedTech innovation hub. With a massive patient population, PLI manufacturing incentives, and a maturing CDSCO regulatory framework, this panel explores what it takes to enter, scale, or partner in India.
Rashmi Kumar
M&A Editor, Asia Pacific
Mergermarket
Ravi Bhogu
Founder & CEO
Monitra Healthcare Private Limited
Dr. Madhu Sasidhar
President & CEO – Hospitals Division
Apollo Hospitals
Jonathan Pieterse
Founder
NXT Horizon
Avijit Dasgupta
Executive Director
Divergent Software Labs
Rafi Sasongko
Investor
Pegasus Tech Ventures
Tony Li
Partner
Fong Capital Partners
Ken Nelson
Investor & Board Member
Nelson Jennings Ventures
Varun Turalapati
Managing Director
Chaanakya Capital
Kelly Qiao
Sr. Principal
B Capital
Marcus Hui
Vice President
GT Healthcare Capital Partners
Sahir Ali
Founder & General Partner
Modi Ventures
Laurent Pachecho
Managing Partner
International Family Office Alliance for Health
Von Leong
Co Founder
Purpose Venture Capital and Philanthropy
David Frankenfield
Operating Partner
Braxton Capital Ventures
Vinern Leow
Vice President
Ascend Capital Partners
MS HUANZHI HU
Project Roadshow Lead
Yinrunkang (Shenzhen) Technology Co. Ltd
Ramil Musin
CEO
LCM Biosensor Technologies
Dr. Weiguo Xie
CEO/CTO & Founder
Würzburg Dynamics (Shenzhen) Ltd
Jacob BenArie
CEO
OnePass Medical
Lukas Hertle
Co-Founder
Monarch Technologies
Meng Ge
CEO
Beijing Best HealthCare Technology Co., Ltd.
Dr. Rafael Veraza
CEO & President
Vascular Perfusion Solutions, Inc. (VPS)
Simon Terhurne
CEO & Co-Founder
Oculoo
Ella Fung
CEO & Co-Founder
Rosalind Dx
Russell Chan
CEO & Co-Founder
E-SENSE Innovation & Technology
12:45 – 13:45
Connect with a select group of healthcare leaders, innovators, and industry experts at our exclusive invite-only luncheon, proudly sponsored by CFGI.
As Asian MedTech companies scale toward exit, liquidity increasingly depends on cross-border structuring, holding company design, dual-track M&A, and IPO readiness. Senior investors, founders, and finance leaders share their insights on deal structuring, tax and entity architecture, and what it takes to close a cross-border exit cleanly.
Peter Liddell
Managing Partner, Singapore
CFGI
Anastasia Miros
Partner
CFGI
Dr. Alex Aliper
Co-Founder and President
Insilico Medicine
Vijay Karwal
Managing Director
CBC Group
Sunil Thakur
Partner and Head of South Asia
Quadria Capital
18:00 – 20:00
The Closing Reception offers one final opportunity to connect with fellow attendees in a relaxed and welcoming setting. Enjoy a complimentary welcome drink at Grand Hyatt, Waterfall Bar as you reflect on the event, strengthen new relationships, and continue conversations before departing.
07:30 – 17:00
The Shenzhen and Greater Bay Area Study Tour, sponsored by Smart City of China, will take place on 29 August and will include visits to Mindray and Alibaba, as well as a high-level exchange session at the Alibaba (Shenzhen) Innovation Center with representatives from the China Centre for Promotion of SME Development under the Ministry of Industry and Information Technology (MIIT) of China.
The program will bring together senior executives from invited Shenzhen-headquartered companies in the medical devices, biopharmaceutical, and medical consumables sectors for in-depth discussions and engagement. The day will feature dialogues on key industry topics, followed by a business lunch and afternoon tea networking sessions throughout the day.
Attendance is strictly by invitation and all confirmed guests would need to have a Platinum ticket access.
Depart from the hotel in Hong Kong and travel to Shenzhen Bay Port.
Visit Mindray and explore one of China’s leading MedTech companies.
Visit Alibaba Group and participate in discussions with representatives from the Ministry of Industry and Information Technology (MIIT) and leading MedTech companies, exploring potential collaboration and business opportunities.
Transfer back to Shenzhen Bay Port. Guests may either return to Hong Kong independently or remain in Shenzhen for leisure.
Connect Before You Arrive
Discover who’s attending, from exhibitors and keynote speakers to industry leaders. Connect, start conversations, explore partnerships, and schedule meetings before the event. Create your profile, showcase your offerings, and share your QR code to make networking easier.
Plan Your Way
With networking at its core, MedTech Match helps you create a personalised event experience. Build your agenda, explore the interactive floor plan, connect with attendees, book meetings, and plan your visit , all within one seamless platform.
Live Events Updates
MedTech Match keeps you updated throughout the event. Discover new speakers, sessions, workshops, and key activities happening across the expo floor. Stay informed, explore opportunities, and make sure you don’t miss a moment.